Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano - Replication - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-10-24 01:27:48		Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano Add to Reading List Source URL: www.takara-bio.co.jp Download Document from Source Website File Size: 325,90 KB Share Document on Facebook